Pharming Group N.V. (PHAR) income statement
PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30
$12.48+0.42 (+3.51%)
Close on Nov 18, 2026Market cap $875.92MP/E 312.1Yield –
Pharming Group N.V. income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- 87.9%
- Operating margin
- 6.9%
- Net margin
- 0.8%
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 2.59
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 125.5%
Valuation
- P/E ratio
- 312.1
- Price to sales
- 2.33
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?